Global health diplomacy is at a crossroads and the COVID-19 pandemic has made this abundantly clear.
Health diplomacy — where domestic and foreign policy decisions intersect with public health – has become a crowded field with major funders, new global health organisations and political clubs such as the G7 and G20 all vying for a seat at the table. This has led to more investment in global health and innovative partnerships, but it’s also created a fragmented and competitive environment due to a lack of cooperation.
These tensions were recognised when G20 health ministers met in Bali, Indonesia last month in a bid to improve global health co-operation and strengthen pandemic prevention, preparedness and response.
